The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 16, 2021

Filed:

Oct. 11, 2017
Applicant:

Wellstat Ophthalmics Corporation, Rockville, MD (US);

Inventors:

Tianci Luo, Fulton, MD (US);

Jun Zhang, Ellicott City, MD (US);

Assignee:

Welltat Ophthalmics Corporation, Rockville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); C07K 14/47 (2006.01); C12N 9/02 (2006.01); C12N 15/86 (2006.01); A61K 47/64 (2017.01); A61P 25/14 (2006.01); A61K 47/42 (2017.01); C07K 14/76 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); C12N 15/85 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A61K 47/42 (2013.01); A61K 47/643 (2017.08); A61P 25/14 (2018.01); C07K 14/47 (2013.01); C07K 14/76 (2013.01); C12N 9/0036 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 15/85 (2013.01); C12N 15/86 (2013.01); C12Y 108/01008 (2013.01); C07K 2319/02 (2013.01); C07K 2319/31 (2013.01); C12N 2750/14143 (2013.01); C12N 2800/22 (2013.01);
Abstract

A fusion protein is described, comprising a first N-terminal signal peptide sequence, a second peptide sequence C-terminal to the signal peptide sequence, and a third peptide sequence C-terminal to the second peptide sequence; wherein one of the second peptide sequence and the third peptide sequence is an RdCVF-short peptide sequence and the other is a hydrophilic peptide sequence. After translation the signal peptide is cleaved, leaving a fusion protein comprising the second peptide sequence and the third peptide sequence minus the signal peptide. Also described are nucleic acids and expression vectors encoding the fusion protein, cells comprising the nucleic acid or expression vector, as well as methods of treatment and uses of the fusion protein, nucleic acid, and expression vector. The fusion protein can be produced in vitro by culturing the cells of this invention under conditions allowing for expression and secretion of the encoded fusion protein, and isolating the fusion protein from the cell culture.


Find Patent Forward Citations

Loading…